Outlook Therapeutics (OTLK) Exchange Rate Effect (2018 - 2019)

Outlook Therapeutics (OTLK) posted quarterly Exchange Rate Effect of $9419.0 for Q2 2019, up 266.35% quarter-over-quarter from -$5662.0 in Q1 2019.

Outlook Therapeutics (OTLK) Exchange Rate Effect (2018 - 2019) Analysis & Trends

Outlook Therapeutics (OTLK) has reported Exchange Rate Effect for 2 consecutive years, with $9419.0 the latest figure, recorded in Q2 2019.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Exchange Rate Effect (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-3.70 Mn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	-300,000.00
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-2.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	19.84 Mn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	-2.45 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	1.63 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-287,000.00
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	Outlook Therapeutics	88.50 Mn	77.26 Mn	-8,265.00	-

Download Data